Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-Cell Depleted HSCT with TBI/Thio/Cy for Pediatric Hematologic Malignancies
NCT00028730Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2001
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, cyclophosphamide in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), non-Hodgkin lymphoma (NHL), myelodysplastic syndrome (MDS), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2001; status: completed.
02
Drugs
thiotepacyclophosphamide
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)non-Hodgkin lymphoma (NHL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00028730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028730.